GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » LT-Debt-to-Total-Asset

Avax Technologies (Avax Technologies) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2008)


View and export this data going back to . Start your Free Trial

What is Avax Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Avax Technologies's long-term debt to total assests ratio for the quarter that ended in Sep. 2008 was 0.00.

Avax Technologies's long-term debt to total assets ratio stayed the same from Sep. 2007 (0.00) to Sep. 2008 (0.00).


Avax Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Avax Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies LT-Debt-to-Total-Asset Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Avax Technologies LT-Debt-to-Total-Asset Calculation

Avax Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2007 is calculated as

LT Debt to Total Assets (A: Dec. 2007 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2007 )/Total Assets (A: Dec. 2007 )
=0/7.377
=0.00

Avax Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2008 is calculated as

LT Debt to Total Assets (Q: Sep. 2008 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2008 )/Total Assets (Q: Sep. 2008 )
=0/1.367
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avax Technologies  (OTCPK:AVXT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Avax Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Avax Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines